Bullseye Biosciences Inc

Bullseye has built a fully automated engine to create medicines that unlock targets and diseases the biopharma industry has written off as impossible and “undruggable.” By harnessing biology’s most proven and powerful technology, evolution, with automation and AI scale data generation, they can go from screen to an orally bioavailable macrocycle in < 9 months — overcoming previous scientific barriers and at a speed few technologies can match. Backed by Illumina Ventures and BARDA with a top-tier advisory board, this is a truly differentiated platform and team aimed at a massive, largely untapped opportunity of >$400B.